Valence Discovery is rethinking drug design to design better drugs. We remain committed to protecting the personal information of our users and clients.
By visiting www.valencediscovery.com (the “Website”), contacting us or agreeing to receive emails from Valence Discovery, you accept the terms and conditions of this policy.
This policy does not extend to websites operated by third parties. Valence Discovery is therefore not liable for their privacy policies, procedures and practices.
A. Information that you send us
We collect your personal information in several ways, including when you contact us by email or sign up for our mailing list. Depending on the circumstances, personal information may include your name, contact information (street address, electronic address, telephone number).
B. Information provided on our Website
We also collect data relating to your visit to our Website. This information may include your IP address, the date, time and duration of your visits as well as the web pages you consulted.
Disabling cookies on your browser could adversely affect your browsing experience on the Website.
We use and disclose your personal information mainly:
When we disclose your personal information to third parties, we take reasonable measures to ensure that the rules set forth in this policy are complied with.
The file will be kept in a secure location and accessed only by authorized personnel.
On written request and subject to proof of identity, you may consult the personal information that we have disclosed, and ask that any necessary corrections be made, where applicable, as authorized or required by law.
However, to make sure that the personal information we maintain about you is accurate and up to date, please inform us immediately of any change in your personal information.
Mila, 6666 rue St Urbain, Montreal, QC, H2S 3H1